==== Front Clin Oral Investig Clin Oral Investig Clinical Oral Investigations 1432-6981 1436-3771 Springer Berlin Heidelberg Berlin/Heidelberg 29766378 2490 10.1007/s00784-018-2490-2 Original Article 2-Methacryloyloxyethyl phosphorylcholine (MPC)-polymer suppresses an increase of oral bacteria: a single-blind, crossover clinical trial http://orcid.org/0000-0002-9020-9478Fujiwara Natsumi nfujiwara@tokushima-u.ac.jp 12 Yumoto Hiromichi 3 Miyamoto Koji 4 Hirota Katsuhiko 15 Nakae Hiromi 67 Tanaka Saya 8 Murakami Keiji 1 Kudo Yasusei 9 Ozaki Kazumi 2 Miyake Yoichiro 17 1 grid.267335.60000 0001 1092 3579Department of Oral Microbiology, Tokushima University Graduate School of Biomedical Sciences, 3-18-15 Kuramoto-cho, Tokushima, Tokushima 770-8504 Japan 2 grid.267335.60000 0001 1092 3579Department of Oral Healthcare Promotion, Tokushima University Graduate School of Biomedical Sciences, 3-18-15 Kuramoto-cho, Tokushima, Tokushima 770-8504 Japan 3 grid.267335.60000 0001 1092 3579Department of Periodontology and Endodontology, Tokushima University Graduate School of Biomedical Sciences, 3-18-15 Kuramoto-cho, Tokushima, Tokushima 770-8504 Japan 4 grid.480261.9Life Science Products Division, NOF Corporation, 4-20-3 Ebisu, Shibuya-ku, Tokyo, 150-6019 Japan 5 grid.471716.20000 0004 0639 8312Present Address: Department of Medical Hygiene, Dental Hygiene Course, Kochi Gakuen College, 292-26 Asahi tenjin-cho, Kochi, Kochi 780-0955 Japan 6 grid.267335.60000 0001 1092 3579Department of Hygiene and Oral Health Science, Tokushima University Graduate School of Biomedical Sciences, 3-18-15 Kuramoto-cho, Tokushima, Tokushima 770-8504 Japan 7 grid.412769.f0000 0001 0672 0015Present Address: Department of Oral Health Sciences, Faculty of Health and Welfare, Tokushima Bunri University, 180 Nishihama, Yamashiro-cho, Tokushima, Tokushima 770-8514 Japan 8 grid.267335.60000 0001 1092 3579School of Oral Health and Welfare, Tokushima University Faculty of Dentistry, 3-18-15 Kuramoto-cho, Tokushima, Tokushima 770-8504 Japan 9 grid.267335.60000 0001 1092 3579Department of Oral Molecular Pathology, Tokushima University Graduate School of Biomedical Sciences, 3-18-15 Kuramoto-cho, Tokushima, Tokushima 770-8504 Japan 16 5 2018 16 5 2018 2019 23 2 739 746 29 9 2017 7 5 2018 © The Author(s) 2018Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.Objectives The biocompatible 2-methacryloyloxyethyl phosphorylcholine (MPC)-polymers, which mimic a biomembrane, reduce protein adsorption and bacterial adhesion and inhibit cell attachment. The aim of this study is to clarify whether MPC-polymer can suppress the bacterial adherence in oral cavity by a crossover design. We also investigated the number of Fusobacterium nucleatum, which is the key bacterium forming dental plaque, in clinical samples. Materials and methods This study was a randomized, placebo-controlled, single-blind, crossover study, with two treatment periods separated by a 2-week washout period. We conducted clinical trial with 20 healthy subjects to evaluate the effect of 5% MPC-polymer mouthwash after 5 h on oral microflora. PBS was used as a control. The bacterial number in the gargling sample before and after intervention was counted by an electronic bacterial counter and a culture method. DNA amounts of total bacteria and F. nucleatum were examined by q-PCR. Results The numbers of total bacteria and oral streptcocci after 5 h of 5% MPC-polymer treatment significantly decreased, compared to the control group. Moreover, the DNA amounts of total bacteria and F. nucleatum significantly decreased by 5% MPC-polymer mouthwash. Conclusions We suggest that MPC-polymer coating in the oral cavity may suppress the oral bacterial adherence. Clinical relevance MPC-polymer can be a potent compound for the control of oral microflora to prevent oral infection. Keywords 2-Methacryloyloxyethyl phosphorylcholineClinical studyOral infectionOral bacteriaFusobacterium nucleatumhttp://dx.doi.org/10.13039/501100001691Japan Society for the Promotion of Science16K21198Fujiwara Natsumi NOF corporationissue-copyright-statement© Springer-Verlag GmbH Germany, part of Springer Nature 2019 ==== Body Introduction Dental caries, periodontal disease, and oral mucosal lesions are major public health problems worldwide, which are caused by oral biofilm. Systemic diseases, such as cardiovascular disease and complications during pregnancy, have been reported to relate with oral microflora [1, 2]. In particular, aspiration pneumonia has been caused by oral bacteria for elderly people and immunocompromised patients [3, 4]. Oral health is closely related with general health and quality of life (QOL) [5]. These facts indicate that it is important to suppress dental plaque formation and development to maintain QOL. In the process of dental plaque formation, acquired enamel pellicle forms on hard tissue such as tooth surface [6], and then, early colonizers were primarily composed of Gram-positive species such as Streptococcus adhere to the surfaces. Secondary colonizers attach primary bacteria already anchored to teeth or tissues, which is important for the development of dental plaque [7, 8]. Fusobacteria play a central role in physical bridges to mediate the co-aggregation of bacterial cells and promote the anaerobic microenvironment [9]. Fusobacterium nucleatum is the predominant species in the healthy oral cavity and markedly increases in the oral cavity with periodontal disease. The inhibition of biofilm formation by periodontopathic bacteria including F. nucleatum, therefore, is regarded as an effective strategy for preventing periodontal diseases. It has been shown that the biological properties of a coating of biocompatible 2-methacryloyloxyethyl phosphorylcholine (MPC)-polymers, which have a phospholipid polar group that mimics a biomembrane, are completely harmless to humans, reducing protein adsorption and bacterial adhesion and inhibiting cell attachment [10–12]. We previously reported that a coating of non-aqueous MPC-polymer on coverslips decreased bacterial adhesion, suppressed biofilm formation, and attributed these effects to the “superhydrophilicity” of MPC-polymer-coated surfaces [13]. MPC-polymer application markedly inhibited both the adherence and biofilm formation of Streptococcus mutans on saliva-coated hydroxyapatite and streptococcal adherence to oral epithelial cells and reduced the adherence of F. nucleatum to streptococcal biofilms in vitro [14]. In the small-scale clinical trial, mouth rinsing with MPC-polymer inhibited the increase of oral bacterial numbers, especially S. mutans in vivo, indicating that MPC-polymer coating in oral cavity can be useful for preventing oral infections including dental caries by preventing microbial adherence to oral surfaces [14]. Clinical effect of MPC-polymer on preventing microbial adherence to oral surfaces needs to verify more details because the previous study was a small-scale trial and parallel study design. The aim of this study is to clarify whether MPC-polymer can suppress bacterial adherence in oral cavity by a crossover clinical trial. We also investigated the number of F. nucleatum, which is the key bacterium forming dental plaque, using clinical samples. Materials and methods Study design The study was a randomized, placebo-controlled, single-blind, crossover study, with two treatment periods separated by a 2-week washout period carried out at Tokushima University between March and July 2016. The flow of two treatments was phosphate buffered saline (PBS, 0.01 M, pH 7.4) as a control followed by 5% MPC-polymer dissolved with sterilized water, or 5% MPC-polymer followed by PBS (Fig. 1a). This clinical trial was approved by the Ethics Committee of Tokushima University Hospital (approval no. 2416).Fig. 1 a The flow of two treatment and washout period. The study was a randomized, placebo-controlled, single-blind, crossover study, with two treatment periods separated by a 2-week washout period. b Flow diagram of this study design phases including enrollment and allocation criteria Subjects The sample size calculation was performed on the basis of our previous results [14]. Based on a standard deviation of 0.9 (the fold increase of bacterial number after intervention), a significant level of α = 0.05, and a statistical power of 0.9, we calculated that 18 subjects would be necessary to detect a statistically significant and clinically relevant difference of δ = 0.9. The subjects were recruited at Tokushima University. We conducted clinical trial with 20 healthy subjects to evaluate the effect of MPC-polymer mouthwash on oral microflora. Subjects who are wearing orthodontic appliances and removable partial dentures, had any antibiotic therapy in the past 3 months, are pregnant, and are breast-feeding women were excluded. All subjects received the two treatments and were analyzed (Fig. 1b). Examination of oral health status Clinical oral examinations were carried out before this clinical intervention. As a caries experience, we used DMF rate. Periodontal index (PI) [15], oral hygiene index (OHI) [16], and tongue coating status evaluation were also used. In the tongue coating status evaluation, the total area was recorded with a score from 0 to 4, where a score of 0 represented no tongue coating; 1, a thin coating of less than one third of the back of the tongue; 2, a thin coating of less than two thirds of the tongue or less than one-third covered with a thick coating; 3, a thin coating of more than two thirds of the tongue, or less than two thirds covered with a thick coating; and 4, more than two thirds of the tongue covered with a thick coating [17]. Evaluation of all examination indexes were performed by two calibrated and trained examiners (NF and HN). Clinical intervention After the subjects brushed their teeth as usual, we harvested an oral bacterial sample by having them gargle with 5 mL of PBS for 20 s in a similar method that was previously reported [18]. Subjects then were treated with 5 mL of 5% MPC-polymer or PBS (control) for 20 s. At 5 h after treatment with 5% MPC-polymer, an oral bacterial sample was taken again by having them gargle with 5 mL of PBS for 20 s. The subjects were prohibited from eating during the 5-h period. Outcome measures were the number and DNA amounts of oral bacteria before and after intervention by using electronic bacterial counter, culture method, and quantitative real-time polymerase chain reaction (q-PCR) (Fig. 2).Fig. 2 Application regimen of one intervention by using a control or 5% MPC-polymer and items of evaluation using the samples. After the subjects brushed their teeth as usual, we harvested an oral bacterial sample by having them gargle with 5 ml of phosphate buffered saline (PBS) for 20 s. Subjects then are treated with 5 ml of 5% MPC-polymer or PBS (as a control) for 20 s. After 5 h of intervention, an oral bacterial sample was taken again. The subjects were prohibited from eating during the 5-h period. Collected gargling samples were enumerated for the number of bacteria using electronic bacterial counter, a culture method and quantitative real-time polymerase chain reaction (q-PCR) Counting the number of oral bacteria The number of total bacteria in the gargling sample before and after intervention was counted by rapid oral bacteria counting system (Panasonic Healthcare Co. Ltd., Osaka, Japan) applying the dielectrophoresis and impedance measurement theory [19]. Fifty microliters of the sample was added in the cup containing its exclusive solution, and the number of total bacteria was automatically counted. The cell numbers in the gargling sample were determined before and after intervention. As the lowest detection limit of this machine is 1 × 105 cells/ml, actual bacterial counts less than this limit were displayed as 1 × 105 cells/ml [20]. The number of bacteria was also counted by a culture method using a spiral plater (model D; Spiral Systems Inc., Cincinnati, OH, USA), which is a device that accurately distributes a liquid sample onto a rotating agar plate for precise bacterial enumeration. Collected samples were diluted 10-fold with saline and 50 μl of diluted samples was inoculated onto agar plates automatically. A blood agar plate (Kyokuto, Tokyo, Japan) supplemented with 5% sheep blood, mitis-salivarius agar plate (Becton Dickinson, Sparks, MD, USA), and mitis-salivarius agar containing 15% sucrose and 3.3 mg/l bacitracin as described previously [21] for total anaerobic bacteria, oral streptococci, and S. mutans, respectively, were used. The plates were incubated at 37 °C for 2 days anaerobically using the Anaeropack system (Mitsubishi Gas Chemical, Tokyo, Japan), and the resulting colonies, i.e. CFU, were counted. The numbers of CFU were determined before and after intervention. Microbial enumeration by q-PCR The collected gargled samples were used for q-PCR with the specific primer pairs based on 16S ribosomal RNA. Samples were first centrifuged for 10 min, and their bacterial genomic DNA was extracted and purified using Maxwell® Rapid Sample Concentrator (RSC) DNA FFPE Kit-PKK Custom (Promega Corporation, Wisconsin, USA) and Maxwell® RSC Instrument (Promega Corporation) according to the manufacturer’s instructions. In this study, we did not exclude DNA from dead cells and extracellular DNA before DNA isolation procedure. Real-time PCR was performed with the Fast SYBR® Green Master Mix (Applied Biosystems, Foster City, CA, USA) using the StepOnePlus Real Time PCR System (Applied Biosystems). The following specific primers were used to amplify fragments of Universal: 5′-TCCTACGGGAGGCAGCAGT-3′ (sense) and 5′-GGACTACCAGGGTATCTAATCCTGTT-3′ (antisense) [22], and 16S rRNA of F. nucleatum: 5′-CGCAGAAGGTGAAAGTCCTGTAT-3′ (sense) and 5′- TGGTCCTCACTGATTCACACAGA-3′ (antisense) [23]. A purified PCR product amplified from F. nucleatum was used for generating a quantitative standard curve. Amplification conditions of the q-PCR were 95 °C for 10 min for initial denaturation, 40 denaturation cycles at 95 °C for 3 s and annealing/extension at 60 °C for 30 s. For the relative quantification, the copy numbers of both bacterial genes were normalized to the copy number of the 16S rRNA gene using threshold cycle (ΔΔCt) method. Threshold cycle values and data analyses were performed by StepOne™ Software v2.2 (Applied Biosystems). The bacterial copy numbers of 5 h after treatment with 5% MPC-polymer were compared to that of 5 h after treatment with PBS (control). Statistical analysis All statistical analyses were evaluated by Student’s t test which is a common parametric test for comparing two groups with normal distributions. q-PCR was conducted in triplicate and statistical analyses were performed. All analyses were performed using SPSS, version 24.0 (SPSS Japan Inc., Tokyo, Japan). Differences were considered significant when probability values were less than 5%. Results Oral health status of subjects We investigated the clinical oral status using DMF rate, PI, OHI, and tongue coating status against 20 subjects before the intervention (Table 1). The mean age of 20 subjects was 30 ± 9.25, and sex distribution of the subjects was 8 males and 12 females. Average rate of DMF index in the subjects was 21.4 ± 15.7%. Averages of PI and OHI were 0.45 ± 0.6 and 0.98 ± 1.1, respectively. Average of tongue coating status was 1.53 ± 0.6.Table 1 Baseline characteristics and clinical oral health status of the subjects Total subjects (n = 20) MPC-PBS group (n = 10) PBS-MPC group (n = 10) Age (years) 30.0 (± 9.3) 30.9 (± 10.1) 29.1 (± 8.8) Female/male 12/8 5/5 7/3 DMF rate (%) 21.4 (± 15.7) 16.5 (± 18.0) 25.8 (± 12.9) Periodontal index (PI) 0.45 (± 0.6) 0.5 (± 0.6) 0.2 (± 0.3) Oral hygiene index (OHI) 0.98 (± 1.1) 1.1 (± 1.0) 0.5 (± 1.0) Tongue coating test 1.53 (± 0.6) 1.6 (± 0.5) 1.4 (± 0.7) Average (standard deviation) Effects of mouthwash with 5% MPC-polymer on the number of oral bacteria We investigated the effect of mouthwash with MPC-polymer on bacterial colonization in the oral cavity of the subjects. The total bacterial numbers after 5 h in MPC-polymer-treated group were significantly lower than that of control group (P < 0.05) by automatic counting using a rapid oral bacteria quantification system (Fig. 3a). Data obtained by culture method also showed that the numbers of CFU after 5 h of total bacteria and oral streptococci in MPC-polymer-treated group were significantly lower than that of control group (P < 0.05 and P < 0.01, respectively) (Fig. 3b, c). In addition, The CFU counts of S. mutans in MPC-polymer-treated group were also lower than that of control group, but there was no statistical significance (Fig. 3d). We also confirmed that the numbers of cells and CFU in control and 5% MPC-polymer-treated group before intervention showed no significant difference.Fig. 3 The effect of mouthwash with 5% MPC-polymer coating on oral bacterial numbers. The bacterial numbers in the gargled sample were counted by an electronic bacterial counter and a culture method. In the culture method, gargling samples were spread on agar plates supplemented with 5% sheep blood, mitis-salivarius (MS) agar plate and MS agar containing 15% sucrose and 3.3 mg/l bacitracin (MSB) plate, using a spiral plater device. Colony-forming units (CFUs) were counted after anaerobic incubation at 37 °C for 2 days. The data using a an electronic bacterial counter and b agar plates supplemented with 5% sheep blood, c MS agar plates and d MSB plates in culture procedure were shown. The numbers of cells and CFU in control and 5% MPC-polymer-treated group before intervention showed no significant difference. Data represent the mean ± S.D. *P < 0.05 and **P < 0.01 The copy numbers of the 16S rRNA gene of total bacteria and F. nucleatum were evaluated by q-PCR. The copy numbers of total bacteria and F. nucleatum in control and 5% MPC-polymer-treated group showed no significant difference before intervention. The copy numbers of total bacteria and F. nucleatum after 5 h in 5% MPC-polymer-treated group were significantly lower than those in control group (P < 0.05) (Fig. 4).Fig. 4 The effect of treatment with 5% MPC-polymer on the copy numbers of 16S rRNA gene of a total bacterial and b Fusobacterium nucleatum numbers by q-PCR. Samples were enumerated for the number of total bacteria and F. nucleatum by q-PCR using specific primer. Before intervention, the copy numbers of 16S rRNA gene of total bacteria and F. nucleatum show no significant difference. Data represent the mean ± S.D. of three independent experiments. *P < 0.05 Discussion It is well known that microorganisms often survive within biofilms, which results in environmental problems and various infectious diseases [24]. During the biofilm formation and its maturation, co-aggregation and co-adhesion of bacteria are critical [9]. Inhibition of bacterial adherence, therefore, has been considered an effective strategy for prevention of infectious diseases. To destroy the biofilm in the oral cavity, many studies have been conducted on the effective strategies in dental hygiene practice. As a mechanical method, tooth brushing and tongue scraping are used to remove microorganisms. Mouthrinses and toothpastes containing antibacterial compounds, such as chlorhexidine, cetylpyridinium chloride (CPC), and triclosan, are commonly used to prevent the growth and the biofilm formation of bacteria. Currently used disinfectants, however, induce adverse effects, such as extrinsic brown staining of teeth and restorations, toxic to mucous membranes, burning sensation, and mouth irritation [25]. Taking into account these disadvantages of the disinfectants, a novel strategy to inhibit the bacterial adherence and dental plaque formation is required. Here, we demonstrated the inhibitory effects of mouthwash with 5% MPC-polymer coating in the oral cavity on the number of oral bacteria by a randomized, crossover clinical study. Importantly, MPC-polymer has been approved by the Food and Drug Administration (FDA) and applied for various purposes, such as contact lenses and cosmetics. We previously have shown that (i) MPC-polymer coating to plastic coverslips reduces retention of human pathogenic microorganisms including Staphylococcus aureus, S. mutans, Pseudomonas aeruginosa, and Candida albicans in vitro [13], and (ii) MPC-polymer application markedly inhibited both the adherence and biofilm formation of S. mutans on saliva-coated hydroxyapatite and oral epithelial cells [14]. These findings show that superhydrophilicity of MPC-polymer-coated surfaces, but not disinfectant action, may inhibit the adherence of pathogenic bacteria to teeth and/or oral mucosa. In addition, MPC-polymer coating has a role for reducing the protein adsorption. However, the salivary proteins included in the acquired enamel pellicle, such as histatin and statherin, have protective effects of demineralization, prevention of acidic dissolution of the teeth, and antibacterial/antifungal effects [26–28]. In the future, therefore, the development of MPC-polymer with the ability of absorbance of selective salivary proteins are desired. Fusobacteria play a central role as physical bridges to mediate the co-aggregation of bacterial cells and promote an anaerobic microenvironment. F. nucleatum is a predominant and key bacterium in the dental plaque formation and closely associates with other periodontal pathogens [9]. Production of hydrogen sulfide by F. nucleatum is known to be associated with halitosis [29]. MPC-polymer coating inhibits the adherence of F. nucleatum to streptococcal biofilms in vitro [14]. Here, we showed that 5% MPC-polymer gargle significantly suppressed the increase of F. nucleatum to 50% (Fig. 4b). These findings suggest that mouthwash with MPC-polymer coating may suppress the adherence of F. nucleatum to the oral cavity and may inhibit the maturation of dental plaque. F. nucleatum has been reported to be involved in the development of colon cancer via activation of oncogenic signaling, recruitment of tumor-infiltrating immune cells, and interference of the host immunity [30–32]. The control of F. nucleatum is important to reduce the risk of colon cancer as well as oral infectious diseases. To count the bacterial number in the oral cavity, we employed the gargling method. Although it is almost impossible to count the actual bacterial number in the oral cavity, we can estimate the actual number from a sample that is appropriately taken. It has been reported that the bacterial number obtained by the gargling method well reflects the number of bacteria that inhabit in the oral cavity [18]. The bacteria adhered to oral mucosa, tooth surfaces, and tongue, therefore, can be collected by the gargling and the bacterial number in the gargling sample may be well correlated to the whole number of bacteria inhabiting in the oral cavity. To assess the number of oral bacteria in gargling sample, we used a device adopted for rapid oral bacteria quantification system (electronic bacterial counter). Although the electronic bacterial counter has a limit of the detection of bacterial counts (less than 105 cells/ml), the number of microorganisms in the saliva usually exceeds 105 cells/ml [20]. The result by an electronic counting method did not show a highly significant difference in comparison with the result by a culture method (Fig. 3a, b). A difference in bacterial viability may be one of the reasons for which there was low significant difference. Moreover, an electronic bacterial counter is lower sensitivity than the culture method. However, the data evaluated by electronic bacterial counter was well correlated with the data evaluated by a culture method (r2 = 0.7814). As the electronic bacterial counter is simple and easy-to-use operation, this device is useful for counting oral bacteria. Therefore, we can easily check the number of oral bacteria in gargling sample from elderly people at home and compromised hosts in a hospital. We will examine the effect of MPC-polymer coating for elderly people and compromised hosts in the future. In conclusion, we suggest that MPC-polymer coating in the oral cavity may suppress the oral bacterial adhesion. We believe that MPC-polymer is a potent compound for the control of oral microflora to prevent oral infection including dental caries, periodontal diseases, and halitosis. In this study, we focused on the oral bacterial adherence after MPC-polymer treatment. To know the initial microorganism recovery after the intervention, we will evaluate the clinical oral health status including the status of tongue coating. As MPC-polymer treatment protected human oral keratinocytes from the damage induced by CPC [33], MPC-polymer can be used for the purpose on the protection from the damage of oral mucosa in combination with other commercially available disinfectants. Acknowledgements The authors thank Dr. T. Amoh (Tokushima University), Mr. Y. Matsushita (Tokushima University), and Mr. H. Motoyama (Tokushima University) for the data analysis in this study. Funding This work was supported by the Japanese Society for the Promotion of Science (JSPS) KAKENHI Grants No. 16 K21198 and NOF corporation. Compliance with ethical standards Conflict of interest The authors declare that they have no conflict of interest. Ethical approval All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent Informed consent was obtained from all individual participants included in the study. ==== Refs References 1. Beck JD Offenbacher S Systemic effects of periodontitis: epidemiology of periodontal disease and cardiovascular disease J Periodontol 2005 76 2089S 2100S 10.1902/jop.2005.76.11-S.2089 2. Xiong X Buekens P Fraser WD Beck J Offenbacher S Periodontal disease and adverse pregnancy outcomes: a systematic review BJOG 2006 113 135 143 10.1111/j.1471-0528.2005.00827.x 16411989 3. Scannapieco FA Mylotte JM Relationships between periodontal disease and bacterial pneumonia J Periodontol 1996 67 1114S 1122S 10.1902/jop.1996.67.10s.1114 4. Terpenning M Geriatric oral health and pneumonia risk Clin Infect Dis 2005 40 1807 1810 10.1086/430603 15909270 5. Petersen PE Bourgeois D Ogawa H Estupinan-Day S Ndiaye C The global burden of oral diseases and risks to oral health Bull World Health Organ 2005 83 661 669 16211157 6. Siqueira WL Custodio W McDonald EE New insights into the composition and functions of the acquired enamel pellicle J Dent Res 2012 91 1110 1118 10.1177/0022034512462578 23018818 7. Kolenbrander PE London J Adhere today, here tomorrow: oral bacterial adherence J Bacteriol 1993 175 3247 3252 10.1128/JB.175.11.3247-3252.1993 8501028 8. Donlan RM Costerton JW Biofilms: survival mechanisms of clinically relevant microorganisms Clin Microbiol Rev 2002 15 167 193 10.1128/CMR.15.2.167-193.2002 11932229 9. Kolenbrander PE Andersen RN Blehert DS Egland PG Foster JS Palmer RJ Jr Communication among oral bacteria Microbiol Mol Biol Rev 2002 66 486 505 10.1128/MMBR.66.3.486-505.2002 12209001 10. Ishihara K Fukumoto K Iwasaki Y Nakabayashi N Modification of polysulfone with phospholipid polymer for improvement of the blood compatibility. Part 2. Protein adsorption and platelet adhesion Biomaterials 1999 20 1553 1559 10.1016/S0142-9612(98)00206-3 10482409 11. Iwasaki Y Aiba Y Morimoto N Nakabayashi N Ishihara K Semiinterpenetrating polymer networks composed of biocompatible phospholipid polymer and segmented polyurethane J Biomed Mater Res 2000 52 701 708 10.1002/1097-4636(20001215)52:4<701::AID-JBM15>3.0.CO;2-6 11033553 12. Lewis AL Cumming ZL Goreish HH Kirkwood LC Tolhurst LA Stratford PW Crosslinkable coatings from phosphorylcholine-based polymers Biomaterials 2001 22 99 111 10.1016/S0142-9612(00)00083-1 11101155 13. Hirota K Murakami K Nemoto K Miyake Y Coating of a surface with 2-methacryloyloxyethyl phosphorylcholine (MPC) co-polymer significantly reduces retention of human pathogenic microorganisms FEMS Microbiol Lett 2005 248 37 45 10.1016/j.femsle.2005.05.019 15953697 14. Hirota K Yumoto H Miyamoto K Yamamoto N Murakami K Hoshino Y Matsuo T Miyake Y MPC-polymer reduces adherence and biofilm formation by oral bacteria J Dent Res 2011 90 900 905 10.1177/0022034511402996 21447697 15. Russell AL The periodontal index J Periodontol 1967 38 585 591 10.1902/jop.1967.38.6_part2.585 16. Greene C Vermillion R The oral hygiene index: a method for classifying oral hygiene status J Am Dent Assoc 1960 61 172 179 10.14219/jada.archive.1960.0177 17. Amou T Hinode D Yoshioka M Grenier D Relationship between halitosis and periodontal disease - associated oral bacteria in tongue coatings Int J Dent Hyg 2014 12 145 151 10.1111/idh.12046 23890391 18. Okuda M Kaneko Y Ichinohe T Ishihara K Okuda K Reduction of potential respiratory pathogens by oral hygienic treatment in patients undergoing endotracheal anesthesia J Anesth 2003 17 84 91 10.1007/s005400300022 12903918 19. Hirota K Inagaki S Hamada R Ishihara K Miyake Y Evaluation of a rapid oral bacteria quantification system using dielectrophoresis and the impedance measurement Biocontrol Sci 2014 19 45 49 10.4265/bio.19.45 24670618 20. Funahara M Hayashida S Sakamoto Y Yanamoto S Kosai K Yanagihara K Umeda M Efficacy of topical antibiotic administration on the inhibition of perioperative oral bacterial growth in oral cancer patients: a preliminary study Int J Oral Maxillofac Surg 2015 44 1225 1230 10.1016/j.ijom.2015.06.002 26119366 21. Mattos-Graner RO Smith DJ King WF Mayer MP Water-insoluble glucan synthesis by mutans streptococcal strains correlates with caries incidence in 12- to 30-month-old children J Dent Res 2000 79 1371 1377 10.1177/00220345000790060401 10890715 22. Nadkarni MA Martin FE Jacques NA Hunter N Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set Microbiology 2002 148 257 266 10.1099/00221287-148-1-257 11782518 23. Suzuki N Yoshida A Saito T Kawada M Nakano Y Quantitative microbiological study of subgingival plaque by real-time PCR shows correlation between levels of Tannerella forsythensis and fusobacterium spp J Clin Microbiol 2004 42 2255 2257 10.1128/JCM.42.5.2255-2257.2004 15131205 24. Costerton JW Stewart PS Greenberg EP Bacterial biofilms: a common cause of persistent infections Science 1999 284 1318 1322 10.1126/science.284.5418.1318 10334980 25. Tilliss TS Stach DJ Cross-Poline GN Use of toothpicks for chlorhexidine staining J Clin Periodontol 1992 19 398 400 10.1111/j.1600-051X.1992.tb00669.x 1634629 26. Delecrode TR Siqueira WL Zaidan FC Bellini MR Moffa EB Mussi MC Xiao Y Buzalaf MA Identification of acid-resistant proteins in acquired enamel pellicle J Dent 2015 43 1470 1475 10.1016/j.jdent.2015.10.009 26498726 27. Moffa EB, Mussi MC, Xiao Y, Garrido SS, Machado MA, Giampaolo ET, Siqueira WL (2015) Histatin 5 inhibits adhesion of C. albicans to reconstructed human oral epithelium. Front Microbiol. 10.3389/fmicb.2015.00885 28. Xiao Y Karttunen M Jalkanen J Mussi MC Liao Y Grohe B Lagugné-Labarthet F Siqueira WL Hydroxyapatite growth inhibition effect of pellicle statherin peptides J Dent Res 2015 94 1106 1112 10.1177/0022034515586769 26116492 29. Pianotti R Lachette S Dills S Desulfuration of cysteine and methionine by Fusobacterium nucleatum J Dent Res 1986 65 913 917 10.1177/00220345860650061101 3458742 30. Rubinstein MR Wang X Liu W Hao Y Cai G Han YW Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/ß-catenin signaling via its FadA Adhesin Cell Host Microbe 2013 14 195 206 10.1016/j.chom.2013.07.012 23954158 31. Kostic AD Chun E Robertson L Glickman JN Gallini CA Michaud M Clancy TE Chung DC Lochhead P Hold GL el-Omar EM Brenner D Fuchs CS Meyerson M Garrett WS Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment Cell Host Microbe 2013 14 207 215 10.1016/j.chom.2013.07.007 23954159 32. Gur C Ibrahim Y Isaacson B Yamin R Abed J Gamliel M Enk J Bar-On Y Stanietsky-Kaynan N Coppenhagen-Glazer S Shussman N Almogy G Cuapio A Hofer E Mevorach D Tabib A Ortenberg R Markel G Miklić K Jonjic S Brennan CA Garrett WS Bachrach G Mandelboim O Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack Immunity 2015 42 344 355 10.1016/j.immuni.2015.01.010 25680274 33. Yumoto H Hirota K Hirao K Miyazaki T Yamamoto N Miyamoto K Murakami K Fujiwara N Matsuo T Miyake Y Anti-inflammatory and protective effects of 2-methacryloyloxyethyl phosphorylcholine polymer on oral epithelial cells J Biomed Mater Res A 2015 103A 555 563 10.1002/jbm.a.35201